Q2 2023
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| HOWL | New | WEREWOLF THERAPEUTICS INC | $1,796,761 | – | 589,102 | – | 38.27% | – |
| New | TSCAN THERAPEUTICS INC | $1,575,000 | – | 630,000 | – | 33.55% | – | |
| VACC | New | VACCITECH PLCads | $1,322,940 | – | 642,204 | – | 28.18% | – |
Q4 2022
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| Exit | TSCAN THERAPEUTICS INC | $0 | – | -630,000 | – | -28.97% | – | |
| VACC | Exit | VACCITECH PLCads | $0 | – | -642,204 | – | -30.98% | – |
| HOWL | Exit | WEREWOLF THERAPEUTICS INC | $0 | – | -589,102 | – | -40.05% | – |
Q2 2022
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| VACC | New | VACCITECH PLCads | $2,858,000 | – | 642,204 | – | 39.43% | – |
| HOWL | New | WEREWOLF THERAPEUTICS INC | $2,409,000 | – | 589,102 | – | 33.24% | – |
| New | TSCAN THERAPEUTICS INC | $1,981,000 | – | 630,000 | – | 27.33% | – |
Q4 2021
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| Exit | TSCAN THERAPEUTICS INC | $0 | – | -630,000 | – | -20.63% | – | |
| VACC | Exit | VACCITECH PLCads | $0 | – | -642,204 | – | -39.68% | – |
| HOWL | Exit | WEREWOLF THERAPEUTICS INC | $0 | – | -589,102 | – | -39.69% | – |
Q3 2021
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| New | TSCAN THERAPEUTICS INC | $5,254,000 | – | 630,000 | – | 20.63% | – |
Q2 2021
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| VACC | New | VACCITECH PLCads | $10,776,000 | – | 642,204 | – | 51.19% | – |
| HOWL | New | WEREWOLF THERAPEUTICS INC | $10,274,000 | – | 589,102 | – | 48.81% | – |